1. Monitoring Microbiological Response to Antituberculosis Therapy by Real-Time PCR
- Author
-
SutjiPratiwi Rahardjo, Mochammad Hatta, Nur Indah Purnamasari, Syamsu Rijal, Nataniel Tandirogang, Rosdiana Natzir, Ressy Dwiyanti, Masyhudi Amir, Andini Febrianty, Muhammad Sabir, Ahmad Adhyka, Yadi Yasir, and Muhammad Reza Primaguna
- Subjects
Messenger RNA ,Bacilli ,Tuberculosis ,biology ,business.industry ,General Medicine ,Ribosomal RNA ,medicine.disease ,biology.organism_classification ,Microbiology ,genomic DNA ,Real-time polymerase chain reaction ,Mrna level ,Immunology ,medicine ,Sputum ,medicine.symptom ,business - Abstract
Background: M. tuberculosis grows slowly and requires several weeks to detect in clinical specimens using standard culture techniques. Messenger RNA is more rapidly destroyed in cells than rRNA or genomic DNA, assays that target mycobacterial mRNA better reflect mycobacterial viability. Therefore we evaluated performance of mRNA for monitoring response to antituberculosis therapy using Real-Time PCR. Methods: Sputum specimens from 29 tuberculosis patients confirmed by positive culture were included in this study. Sputum specimens were collected before therapy, at 1st week, 4th week, 8th week and 16th week after initiating antituberculosis therapy to evaluate acid-fast bacilli (AFB), culture and mRNA level. Results: All 29 specimens were positive for culture and mRNA before initiating tuberculosis chemotherapy. Within 29 samples confirmed by positive culture, only 22 (75.9%) patients were positive by AFB. After 8 and 16 weeks of therapy, 27 (93.1%) and 28 (96.5%) were negative by culture, 26 (89.6%) and 28 (96.5%) were negative results for mRNA, and 15 (51.7%) and 29 (100%) were negative results for AFB. Conclusion: Rapidly decline of mRNA level correlated with rapid culture clearance after anti-tuberculosis therapy.
- Published
- 2015
- Full Text
- View/download PDF